Search & Analyze

Ajanta Pharma Ltd.

HealthcarePharmaceuticals & Drugs

www.ajantapharma.com BSE: 532331NSE: AJANTPHARM

₹3,300.00BSE0.90%

23 Oct, 4:01 PM

₹3,300.00

₹41.00K Cr

36.13

8.44

25.42%

₹3,350.05

₹3,219.95

₹3,796.95

₹2,381.50

Customise metrics bar

Ajanta Pharma Ltd. (AJANTPHARM) share price closed at ₹3,300.00 on the BSE on Friday, October 23, 2026, up by 0.90% from its of ₹3,270.65. In that session AJANTPHARM reached a of 3,350.05 and of 3,219.95. The for the session was 3,289.34. The stands at 3,514.05 and is at 3,151.57. Looking at , the stock ended the session in Uptrend.

Stock Overview

Symbol

AJANTPHARM

₹3,280.05

₹3,270.65

₹3,289.34

₹3,514.05

Price 6.09% below

₹3,151.57

Price 4.71% above

61.53% of range

₹3,219.95₹3,350.05

64.89% of range

₹2,381.50₹3,796.95

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,743.00	34.58	4,18,204.09	0.92	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	8,984.00	81.54	2,38,496.97	0.33	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,482.00	80.26	1,70,480.87	0.85	534.00	-9.64%	4,979.00	50.79%	19.27
ZYDUSLIFE ZYDUSLIFE	1,127.85	24.93	1,12,503.47	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,337.00	32.04	1,08,012.30	0.97	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,974.00	97.55	1,06,657.63	0.10	362.07	123.94%	2,026.31	29.10%	18.20
DR.REDDY'S DRREDDY	1,224.50	36.50	1,02,206.60	0.65	913.20	-31.69%	8,697.80	-1.48%	13.75
Ajanta Pharma Ltd. AJANTPHARM	3,300.00	36.13	41,000.93	0.85	334.22	30.89%	1,625.96	24.82%	32.67

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,144.92	1,186.64	1,146.13	1,170.41	1,302.65	1,353.73	1,374.84	1,421.64	1,625.96
Expenses	814.57	875.47	825.30	873.26	951.30	1,025.90	992.60	1,088.23	1,202.38
	330.35	311.17	320.83	297.15	351.35	327.83	382.24	333.41	423.58
	28.85%	26.22%	27.99%	25.39%	26.97%	24.22%	27.80%	23.45%	26.05%
	26.47	19.48	30.44	18.11	26.33	59.34	24.97	61.43	70.90
Interest	0.73	6.02	7.91	6.07	5.26	3.39	5.10	2.36	3.18
	33.97	34.39	35.97	39.78	41.29	42.97	43.51	45.37	44.50
	322.12	290.24	307.39	269.41	331.13	340.81	358.60	347.11	446.80
	23.70%	25.41%	24.24%	16.39%	22.89%	23.66%	23.66%	23.17%	25.20%
	245.77	216.48	232.88	225.26	255.34	260.19	273.77	266.70	334.22
	19.61	17.27	18.58	17.97	20.37	20.76	21.84	21.28	26.66

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	3,395.53	7,168.22	7,978.80	8,902.84	11,293.22
	3,340.99	3,742.64	4,208.71	4,648.10	5,452.86
EXPENDITURE :
Increase/Decrease in Stock	-83.17	25.76	-39.21	-25.64	37.46
Raw Material Consumed	760.90	843.55	919.34	917.83	958.29
Power & Fuel Cost	54.38	65.71	66.57	70.34	73.29
Employee Cost	645.78	785.14	900.34	1,089.69	1,291.15
Other Manufacturing Expenses	275.42	320.81	303.29	322.39	355.00
General and Administration Expenses	300.83	365.86	382.26	435.55	487.54
Selling and Distribution Expenses	400.29	463.94	417.54	482.41	651.20
Miscellaneous Expenses	57.27	88.62	86.64	96.03	204.10
	2,411.70	2,959.39	3,036.77	3,388.60	4,058.03
Operating Profit (Excl OI)	929.29	783.25	1,171.94	1,259.50	1,394.83
	115.68	98.64	84.60	94.50	172.07
	1,044.97	881.89	1,256.54	1,354.00	1,566.90
Interest	10.20	5.84	7.21	20.73	16.11
PBDT	1,034.77	876.05	1,249.33	1,333.27	1,550.79
	125.29	130.80	135.40	144.11	173.14
Profit Before Taxation & Exceptional Items	909.48	745.25	1,113.93	1,189.16	1,377.65
	909.48	745.25	1,113.93	1,189.16	1,377.65
Provision for Tax	196.80	157.27	297.76	268.77	321.65
	712.68	587.98	816.17	920.39	1,056.00
Extra items			0.00	0.00	0.00
Consolidated Net Profit	712.68	587.98	816.17	920.39	1,056.00
Profit Balance B/F	2,155.73	2,717.70	3,141.27	3,314.35	3,671.88
Appropriations	2,868.41	3,305.68	3,957.44	4,234.74	4,727.88
Equity Dividend %	475.00%	350.00%	2,550.00%	1,400.00%	1,400.00%
	83.45	46.70	64.83	73.69	84.55
Adjusted EPS	55.63	46.70	64.83	73.69	84.55

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	17.17	25.27	25.27	25.07	25.07
Share Warrants & Outstandings	0.30	0.34	5.65	5.18	3.22
Total Reserves	3,246.87	3,362.38	3,536.44	3,760.04	4,498.80
Reserve excluding Revaluation Reserve	3,246.87	3,362.38	3,536.44	3,760.04	4,498.80
	3,264.34	3,387.99	3,567.36	3,790.29	4,527.09
Secured Loans	1.64	1.25
Deferred Tax Assets / Liabilities	46.32	0.95	-25.95	-75.91	-70.65
Other Long Term Liabilities	21.02	28.63	27.23	37.77	42.91
Long Term Provisions	216.04	146.55	39.54	80.27	60.26
Total Non-Current Liabilities	285.02	177.38	40.82	42.13	32.52
Trade Payables	327.17	422.77	463.20	454.20	544.30
Other Current Liabilities	301.47	669.42	369.52	478.02	628.68
Short Term Borrowings					206.89
Short Term Provisions	18.75	47.09	62.53	352.76	307.09
Total Current Liabilities	647.39	1,139.28	895.25	1,284.98	1,686.96
Total Liabilities	4,196.75	4,704.65	4,503.94	5,117.40	6,246.57
Gross Block	2,206.86	2,282.82	2,389.41	2,801.05	3,046.33
Less: Accumulated Depreciation	703.28	786.38	910.22	1,039.03	1,179.38
Net Block	1,503.58	1,496.44	1,479.19	1,762.02	1,866.95
Capital Work in Progress	152.86	209.47	256.45	176.27	258.05
Non Current Investments	25.10	25.10	18.58	25.24	28.50
Long Term Investment	25.10	25.10	18.58	25.24	28.50
Long Term Loans & Advances	236.46	134.79	14.43	18.25	84.86
Other Non Current Assets	5.88	4.85	4.37	3.71	1.57
Total Non-Current Assets	1,932.29	1,870.65	1,773.02	1,985.49	2,239.93
Currents Investments	121.86	510.27	330.05	438.71	559.85
Inventories	791.07	815.63	828.36	903.85	938.54
Sundry Debtors	1,019.81	1,056.90	1,246.84	1,182.74	1,853.88
Cash and Bank	211.79	330.90	130.77	176.24	104.77
Other Current Assets	34.79	22.09	53.76	38.80	52.62
Short Term Loans and Advances	85.14	89.39	132.29	378.24	496.98
Total Current Assets	2,264.46	2,825.18	2,722.07	3,118.58	4,006.64
Net Current Assets (Including Current Investments)	1,617.07	1,685.90	1,826.82	1,833.60	2,319.68
Total Assets	4,196.75	4,704.65	4,503.94	5,117.40	6,246.57
Contingent Liabilities	6.76	4.03	4.42	8.12	8.12
Total Debt	1.91	1.43	1.49	2.59	211.99
	382.20	269.07	282.89	303.04	362.19
Adjusted Book Value	254.80	269.07	282.89	303.04	362.19

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	909.48	745.25	1,113.93	1,189.16	1,377.65
Adjustment	91.75	131.30	83.03	112.11	163.46
Changes In working Capital	-200.39	66.85	-99.76	178.93	-652.93
Cash Flow after changes in Working Capital	800.84	943.40	1,097.20	1,480.20	888.18
Cash Flow from Operating Activities	561.71	792.11	785.07	1,157.23	529.19
Cash Flow from Investing Activities	-74.10	-559.60	65.39	-376.52	-428.92
Cash Flow from Financing Activitie	-459.71	-108.20	-1,051.06	-733.41	-167.92
Net Cash Inflow / Outflow	27.90	124.31	-200.60	47.30	-67.65
Opening Cash & Cash Equivalents	177.51	206.36	329.83	129.49	175.12
Closing Cash & Cash Equivalent	205.41	330.67	129.23	176.79	107.47

Ratios

Valuation

36.13

8.44

24.42

7.10

90.82

388.77

Profitability

25.42

32.67

18.59

12.35

9.35

Leverage & Liquidity

0.05

2.38

86.52

Returns

0.85

1.99

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	66.27	66.26	66.26	66.26	66.26	66.25	66.25	66.25	63.48	63.47
	25.78	26.22	26.29	26.35	26.37	26.44	26.57	26.64	29.48	29.57
	7.94	7.52	7.45	7.39	7.38	7.32	7.19	7.12	7.03	6.96
	33.73	33.74	33.74	33.74	33.74	33.75	33.75	33.75	36.52	36.53
No. of Shareholders	70,316	64,315	66,896	70,827	68,882	67,785	65,409	67,955	65,296	61,923

Mutual Funds Invested(198)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 117 active funds hold 17.52% in Ajanta Pharma Ltd., contributing to ₹7.93K Cr of holdings

Fund				As of
NI Nippon India Small Cap Fund - Growth - Direct PlanSmall cap Fund	606.29	0.75	16,74,471	Sep '26
KO Kotak Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	585.54	1.10	16,17,147	Sep '26
UT UTI Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	476.94	2.12	13,17,224	Sep '26
KO Kotak Small Cap Fund - Growth - Direct PlanSmall cap Fund	393.27	2.05	10,86,134	Sep '26
KO Kotak Large & Mid Cap Fund - Growth - Direct PlanLarge & Mid Cap	356.70	1.17	9,85,144	Sep '26
NI Nippon India Pharma Fund - Growth - Direct PlanPharma & Health Care	330.91	3.61	9,13,918	Sep '26
HD HDFC Large & Mid Cap Fund - Growth - Direct PlanLarge & Mid Cap	324.87	1.14	8,97,224	Sep '26
CR Canara Robeco Small Cap Fund - Growth - Direct PlanSmall cap Fund	270.49	1.94	7,47,040	Sep '26
NI Nippon India Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	268.86	0.50	7,42,553	Sep '26
UT UTI Mid Cap Fund - Growth - Direct PlanMid Cap Fund	256.26	2.15	7,07,737	Sep '26

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-10-15	Board Meeting	Quarterly Results
2026-07-20	Ex Dividend	Interim Dividend	2026-08-05	2026-08-05
2026-07-20	Board Meeting	Quarterly Results & Interim Dividend

Insider Trading

Date	Person	Category	Transaction Type	Shares
2026-06-29	A V JAYAKUMAR	Market	Sell	2,500
2026-06-29	JAGDISH DWARKADAS JOSHI	Market	Sell	725
2026-06-09	RAVI P AGRAWAL TRUSTEE RAVI AGRAWAL TRUST	Market	Sell	3,450,000

Sector Overview

HealthcarePharmaceuticals & Drugs

Ajanta Pharma Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

9 members across the board and senior leadership

Gaurang Shah

Sr. VP – Legal & Company Secretary, Compliance Officer

—

Mannalal B Agrawal

Chairman

₹8.24 L

Mar '26

Madhusudan B Agrawal

Vice Chairman

₹5.28 Cr

Mar '26

Yogesh M Agrawal

Managing Director

₹27.53 Cr

Mar '26

Rajesh M Agrawal

Joint Managing Director

₹27.53 Cr

Mar '26

David Rasquinha

Non Executive Independent Director

₹12.70 L

Mar '26

Medha Joshi

Non Executive Independent Director

₹10.16 L

Mar '26

Rajesh Dalal

Non Executive Independent Director

₹11.78 L

Mar '26

Simi Thapar

Non Executive Independent Director

₹9.62 L

Mar '26

AJANTPHARM Latest News

News

10 of 10 articles

EQUITY21 Oct 2026 · 14:53

Ajanta Pharma informs about disclosures

EQUITY15 Oct 2026 · 15:20

Ajanta Pharma informs about board meeting

EQUITY15 Oct 2026 · 11:34

Ajanta Pharma informs about newspaper advertisement

EQUITY28 Sept 2026 · 11:47

Ajanta Pharma informs about closure of trading window

EQUITY25 Sept 2026 · 11:55

Ajanta Pharma informs about closure of trading window

EQUITY31 Aug 2026 · 11:07

Ajanta Pharma informs about newspaper publication

EQUITY20 Jul 2026 · 17:13

Ajanta Pharma informs about conference call

EQUITY20 Jul 2026 · 12:26

Ajanta Pharma informs about board meeting

EQUITY14 Jul 2026 · 11:20

Ajanta Pharma informs about substantial acquisition of shares & takeovers

EQUITY7 Jul 2026 · 12:14

Ajanta Pharma informs about certificate

AJANTPHARM

₹3,300.00

+0.9%